Painful salivary swelling in patients with Sjögren syndrome presents the clinician with a difficult-to-manage condition, and treatment options are limited. We report 2 cases that demonstrate the utility of a clinic-based intraductal corticosteroid infusion for the treatment of painful salivary swelling associated with Sjögren syndrome. Steroid infusion is a cost-effective, simple-to-perform, well-tolerated gland-sparing procedure that may yield good clinical results in selected patients.
Introduction
Sjögren syndrome is an autoimmune disorder characterized by lymphocytic infiltration of the exocrine glands. 1 It affects the oral cavity by way of xerostomia, dysphagia, progressive dental caries, fungal infections, and oral pain. 2 Classically, treatment has involved symptom control, addressing dental caries, treating fungal infections, and stimulating and supplementing salivary gland production, 2 as well as drug therapy with systemic corticosteroids, cytokines, and other disease-modifying agents. 1 Unfortunately, attempts at systemic control have yielded mixed results. 1 We describe 2 cases of painful salivary swelling associated with Sjögren syndrome that demonstrate the utility of clinic-based treatment with intraductal steroid infusion.
Case reports Patient 1.
A 66-year-old woman with Sjögren syndrome presented with a 10-year history of intermittent bilateral preauricular swelling and pain, dry eyes, and dry mouth. The swelling occurred several times each week, and it was partially relieved by massage.
On examination, the patient exhibited nontender parotid glands bilaterally. Clear saliva was easily expressed from both Stensen ducts. A workup that had been performed 4 years earlier identified the patient as positive for antinuclear antibodies and anti-SSA and anti-SSB antibodies; the results of a lip biopsy were consistent with the diagnosis of Sjögren syndrome.
Treatment was initiated with oral hydroxychloroquine at 400 mg/day, but this regimen was stopped after 2 years when the patient reported no benefit. Recent findings on computed tomography (CT) were also consistent with Sjögren syndrome; CT demonstrated bilateral enlargement of the parotid glands with fatty infiltration, as well as a mottled pattern of increased enhancement of the parotid and submandibular glands consistent with parotitis. Sialography of the right parotid area identified a moderate to severe stenosis in the midportion of the parotid duct; the ductal system exhibited a marked irregularity, with multiple focal outpouchings of contrast accumulation (figure).
The patient was taken to the operating room for sialendoscopy of both parotid glands, dilation of the parotid ducts, and steroid infusions. Crawford and Ziegler dilators were used to dilate the ductal orifices. An Erlangen Mini-Sialendoscopy 0° telescope (Karl Storz; Tuttlingen, Germany) with an outer diameter of 0.8 mm was placed. Both proximal and distal strictures were noted in the right duct. Strictures were dilated with a 4 × 10-mm salivary balloon dilator inflated with 1.2 ml of sterile water. Then, triamcinolone was injected into both parotid ducts.
One week later, the patient was symptom-free with regard to parotid swelling and pain, and she remained so for 3 months. At that point, however, her symptoms returned. A repeat steroid irrigation of both parotid ducts was performed in clinic; lidocaine-soaked gauze was applied to the buccal mucosa for topical anesthesia. The Stensen ducts were identified under microscopic visualization, and a 0.018-inch guide wire was introduced. A 22-gauge angiocatheter was slid over the wire into the ducts, and the guide wire was removed. This time, 3 ml of triamcinolone (30 mg) was infused-3 ml into each duct. The catheter was left in place with a syringe attached for 2 minutes to prevent the immediate escape of the steroid infusion. The procedure took less than 10 minutes. One week later, the patient was again symptom-free, and this lasted for 3 months. Subsequently, the in-clinic procedure was performed three more times, each time after symptoms recurred. However, the length of time that the patient remained symptom-free increased after every treatment, with the effects of the most recent injections lasting 8 months.
Patient 2. A 62-year-old woman with Sjögren syndrome presented with a clinical history similar to that of patient 1 and with similar findings on serology and a lip biopsy. Sialography demonstrated intraglandular ducts that were attenuated and markedly separated by the diffusely enlarged gland. The parenchyma demonstrated a heterogeneous blush, but no focal sialectasis was noted.
In this patient, no sialendoscopy or dilation was performed. She was treated only with an in-clinic bilateral parotid duct infusion of 3 ml of triamcinolone (30 mg) into each duct. At 2 months of follow-up she was symptom-free.
Discussion
In 1998, Izumi et al reported that steroid irrigation of the parotid gland significantly increased salivary flow rate in patients with Sjögren syndrome. 3 They suggested that steroid irrigation is a viable treatment for relieving xerostomia. In our practice, we have noticed the benefits of steroid irrigation after dilation of strictures during sialendoscopy. These benefits have been reported by others, including in patients with Sjögren syndrome. 4, 5 Our experience since 2011 suggests that irrigation with a steroid alone can help control the swelling and pain associated with Sjögren syndrome.
Drug delivery through the salivary duct offers many possibilities. In fact, intraductal instillation of penicillin or saline has been reported to be a successful technique for treating chronic sialadenitis. 6 We propose that Sjögren syndrome can be treated not only with intraductal steroid infusions, but also with other disease-modifying agents. The salivary ducts might be a viable route for tissue-directed delivery of other therapeutic agents. Such a local insufflation would likely provide higher tissue concentrations than those that can be delivered by systemic treatment.
In conclusion, clinic-based intraductal steroid infusion opens our clinical practice to a new patient population. In addition, it is economical and efficient, and it is a simple procedure that can be performed in the microscope room in the clinic. The procedure took less than 10 minutes to perform, and it provided relief for the patients treated. The initial success that we have observed warrants further investigation, and additional patient trials are indicated. 
